Torabi-Parizi, Parizad, M.D.
individual record
Assistant Clinical Investigator
Positions:
- Assistant Clinical Investigator, Critical Care Medicine Department
overview
Dr. Torabi-Parizi earned her undergraduate degree and degree in Medicine from Emory University. She completed her internship and residency training in Internal Medicine at the Johns Hopkins Hospital Osler Training Program. Dr. Torabi-Parizi completed her fellowship training in Critical Care Medicine at the NIH and was subsequently appointed as Staff Clinician in the Critical Care Medicine Department at the NIH in 2011. She became an Assistant Clinical Investigator in the Critical Care Medicine Department in 2013. She also chairs the Clinical Center CPR committee.
selected publications
Academic Articles21
- (2020). Inhibitory Immune Checkpoint Molecule Expression in Clinical Sepsis Studies: A Systematic Review. CRITICAL CARE MEDICINE. 48(9), 1365-1374.
- (2020). Checkpoint inhibitor therapy in preclinical sepsis models: a systematic review and meta-analysis. Intensive Care Medicine Experimental. 8(1),
- (2019). The Chemoattractant Receptor Ebi2 Drives Intranodal Naive CD4(+) T Cell Peripheralization to Promote Effective Adaptive Immunity. IMMUNITY. 50(5), 1188-+.
- (2018). Mechanisms and Targeted Therapies for Pseudomonas aeruginosa Lung Infection. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. 197(6), 708-727.
- (2017). Bacillus anthracis Edema Toxin Increases Fractional Free Water and Sodium Reabsorption in an Isolated Perfused Rat Kidney Model. INFECTION AND IMMUNITY. 85(7),
- (2015). Caring for Critically Ill Patients Infected With the Ebola Virus Logistic and Human Challenges Response. CHEST. 148(2), E65-E65.
- (2015). Critical Care Management of Two Patients With Ebola: A Biocontainment Unit Demystified. CRITICAL CARE MEDICINE. 43(6), 1326-1327.
- (2015). Ethical and Practical Considerations in Providing Critical Care to Patients With Ebola Virus Disease. CHEST. 147(6), 1460-1466.
- (2015). Network representations of immune system complexity. Wiley Interdisciplinary Reviews-Systems Biology and Medicine. 7(1), 13-38.
- (2015). Strategically Localized Dendritic Cells Promote Rapid T Cell Responses to Lymph-Borne Particulate Antigens. IMMUNITY. 42(1), 172-185.
- (2014). Pathogen-Related Differences in the Abundance of Presented Antigen Are Reflected in CD4(+) T Cell Dynamic Behavior and Effector Function in the Lung. JOURNAL OF IMMUNOLOGY. 192(4), 1651-1660.
- (2014). Tuning of Antigen Sensitivity by T Cell Receptor-Dependent Negative Feedback Controls T Cell Effector Function in Inflamed Tissues. IMMUNITY. 40(2), 235-247.
- (2014). Visualization and dynamic analysis of host-pathogen interactions. CURRENT OPINION IN IMMUNOLOGY. 29, 8-15.
- (2013). Analysis of naive lung CD4 T cells provides evidence of functional lung to lymph node migration. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 110(5), 1821-1826.
- (2013). Retinoic acid controls the homeostasis of pre-cDC-derived splenic and intestinal dendritic cells. JOURNAL OF EXPERIMENTAL MEDICINE. 210(10), 1961-1976.
- (2012). A Spatially-Organized Multicellular Innate Immune Response in Lymph Nodes Limits Systemic Pathogen Spread. CELL. 150(6), 1235-1248.
- (2012). Cold Urticaria, Immunodeficiency, and Autoimmunity Related to PLCG2 Deletions. NEW ENGLAND JOURNAL OF MEDICINE. 366(4), 330-338.
- (2010). Pharmacokinetics of Liposomal Amphotericin B in Pleural Fluid. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 54(4), 1633-1635.
- (2005). Central memory self/tumor-reactive CD8(+) T cells confer superior antitumor immunity compared with effector memory T cells. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 102(27), 9571-9576.